Proteinea

company

About

Engineering proteins to tackle life-threatening diseases with an eye on accessibility.

  • 11 - 50

Details

Last Funding Type
Convertable Note
Industries
Biotechnology
Founded date
Jan 1, 2020
Number Of Employee
11 - 50
Operating Status
Active

Proteinea makes biotherapeutics design smarter, safer, and faster by leveraging novel deep-learning models & platforms integrated with smart experimental throughput.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Proteinea has raised a total of — in funding over 2 rounds. Their latest funding was raised on Jan 1, 2020 from a Convertable Note round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 1, 2020 Convertable Note 1 500 Global Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Proteinea is funded by 1 investors. 500 Global are the most recent investors.
Investor Name Lead Investor Funding Round
500 Global Yes Convertable Note